HRP20191304T4 - Antigljivični pripravak i postupci liječenja - Google Patents

Antigljivični pripravak i postupci liječenja Download PDF

Info

Publication number
HRP20191304T4
HRP20191304T4 HRP20191304TT HRP20191304T HRP20191304T4 HR P20191304 T4 HRP20191304 T4 HR P20191304T4 HR P20191304T T HRP20191304T T HR P20191304TT HR P20191304 T HRP20191304 T HR P20191304T HR P20191304 T4 HRP20191304 T4 HR P20191304T4
Authority
HR
Croatia
Prior art keywords
preparation
topical
antifungal agent
preparation according
infection
Prior art date
Application number
HRP20191304TT
Other languages
English (en)
Croatian (hr)
Inventor
John Ridden
Michael Davies
Liam Good
Original Assignee
Blueberry Therapeutics Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49553377&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20191304(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Blueberry Therapeutics Limited filed Critical Blueberry Therapeutics Limited
Publication of HRP20191304T1 publication Critical patent/HRP20191304T1/hr
Publication of HRP20191304T4 publication Critical patent/HRP20191304T4/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0023—Drug applicators using microneedles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medical Informatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HRP20191304TT 2013-09-25 2014-09-25 Antigljivični pripravak i postupci liječenja HRP20191304T4 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GBGB1317005.5A GB201317005D0 (en) 2013-09-25 2013-09-25 Composition and methods of treatment
GBGB1320723.8A GB201320723D0 (en) 2013-09-25 2013-11-25 Composition and methods of treatment
EP14781264.8A EP3049056B2 (en) 2013-09-25 2014-09-25 Antifungal topical composition and methods of treatment
PCT/GB2014/052911 WO2015044669A1 (en) 2013-09-25 2014-09-25 Antifungal topical composition and methods of treatment

Publications (2)

Publication Number Publication Date
HRP20191304T1 HRP20191304T1 (hr) 2019-10-18
HRP20191304T4 true HRP20191304T4 (hr) 2022-07-22

Family

ID=49553377

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20191304TT HRP20191304T4 (hr) 2013-09-25 2014-09-25 Antigljivični pripravak i postupci liječenja

Country Status (17)

Country Link
US (2) US11185511B2 (https=)
EP (3) EP3501498B1 (https=)
JP (2) JP6581569B2 (https=)
CN (1) CN105579028B (https=)
CY (1) CY1123414T1 (https=)
DK (1) DK3049056T4 (https=)
ES (2) ES2859518T3 (https=)
GB (2) GB201317005D0 (https=)
HR (1) HRP20191304T4 (https=)
HU (1) HUE044589T2 (https=)
LT (1) LT3049056T (https=)
PL (1) PL3049056T5 (https=)
PT (1) PT3049056T (https=)
RS (1) RS59211B2 (https=)
SI (1) SI3049056T2 (https=)
SM (1) SMT201900437T1 (https=)
WO (1) WO2015044669A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201317005D0 (en) * 2013-09-25 2013-11-06 Blueberry Therapeutics Ltd Composition and methods of treatment
US12290599B2 (en) 2015-06-19 2025-05-06 Global Health Solutions Llc Oil-based wound care compositions and methods
US11110071B2 (en) * 2015-06-19 2021-09-07 Global Health Solutions Llc Petrolatum-based PHMB compositions and methods of treatment for onychomycosis
GB201511799D0 (en) * 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment
EP3393518B1 (en) * 2015-12-23 2024-10-30 Aarhus Universitet Antifungal agent
JP7021182B2 (ja) * 2016-03-24 2022-02-16 ロケート・バイオ・リミテッド 足場材料、方法および使用
GB201605127D0 (en) * 2016-03-25 2016-05-11 Blueberry Therapeutics Ltd Composition and methods of treatment
JP6310977B2 (ja) * 2016-09-07 2018-04-11 株式会社日本総合研究所 爪用シール及びシールシート
WO2018162271A1 (en) 2017-03-05 2018-09-13 Rita Dobmeyer Nanoparticles for the treatment of macular degeneration
GB201710491D0 (en) * 2017-06-30 2017-08-16 Blueberry Therapeutics Ltd Composition and methods of treatment
KR102060138B1 (ko) * 2018-05-30 2019-12-27 연세대학교 산학협력단 안구용 마이크로니들 주사의 제조방법
GB201810925D0 (en) * 2018-07-03 2018-08-15 Blueberry Therapeutics Ltd Compositions and methods of treatment
GB201810923D0 (en) * 2018-07-03 2018-08-15 Blueberry Therapeutics Ltd Compositions and method of treatment
US12115139B2 (en) * 2018-08-15 2024-10-15 Todd Alan Weinfield Treatment methods and processes for an infected nail
BR112021014070A2 (pt) * 2019-01-16 2021-09-21 Global Health Solutions Llc Composições de phmb à base de petrolato e métodos de tratamento para onicomicose
GB201908229D0 (en) * 2019-06-10 2019-07-24 Univ College Cork National Univ Of Ireland Microneedles and methods for the manufacture thereof
CN110898075B (zh) * 2019-12-27 2021-08-03 温海 聚六亚甲基双胍在制备抑制和/或杀灭犬小孢子菌的药物中的应用
CN111067897A (zh) * 2020-01-20 2020-04-28 中山大学 一种抗真菌的组合物及其应用
TW202140036A (zh) * 2020-02-26 2021-11-01 挪威商拜歐賽爾根公司 治療性多烯巨環內酯(polyene macrolide)之醫藥組合物及其使用方法
CN111588689B (zh) * 2020-06-20 2023-08-11 温州医科大学 一种角膜微创可溶性微针贴片及其制备方法与应用
CN112168845A (zh) * 2020-11-13 2021-01-05 郑虹 一种用于治疗手足癣的药物软膏及其制备方法
JP2022118704A (ja) * 2021-02-02 2022-08-15 国立大学法人 鹿児島大学 ナノ粒子組成物、抗菌抗かび抗ウイルス剤、抗菌抗かび抗ウイルス塗料、抗菌抗かび抗ウイルス剤調製キット及びナノ粒子組成物の製造方法
DE102021118997A1 (de) * 2021-07-22 2023-01-26 Lts Lohmann Therapie-Systeme Ag. Mikronadelarray mit Antiseptika
CN113567217A (zh) * 2021-07-27 2021-10-29 肖波 一种妇科荧光染色液
WO2023154464A1 (en) * 2022-02-11 2023-08-17 Fairleigh Dickinson University Locally administered compositions and methods of use thereof
KR102597564B1 (ko) * 2023-03-03 2023-11-03 장병모 조갑 및 피부 백선의 예방 또는 치료용 약학적 조성물
CN117563121A (zh) * 2023-11-30 2024-02-20 北京化工大学 一种用于治疗趾间型足癣的集成式可分离微针装置

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2761886B1 (fr) * 1997-04-14 2000-05-05 Virbac Sa Compositions contenant au moins un polymere cationique et au moins une molecule active contenue dans au moins un vecteur micro ou nanoparticulaire, et leur utilisation pour le traitement de surfaces vivantes ou inertes
US20020009491A1 (en) 2000-02-14 2002-01-24 Rothbard Jonathan B. Compositions and methods for enhancing drug delivery across biological membranes and tissues
EP2106805B1 (en) * 2003-03-21 2011-06-15 Nexmed Holdings, Inc. Antifungal nail coat and method of use
JP2007534620A (ja) * 2003-07-17 2007-11-29 ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 第４級アンモニウム化合物と精油および／またはその構成要素の相乗的組合せを含む抗菌組成物
US20050238672A1 (en) * 2004-04-27 2005-10-27 Nimni Marcel E Antifungal drug delivery
EP1755624A4 (en) 2004-05-03 2009-04-29 Neosil Inc POLYCENTRIC ANTIMICROBIAL THERAPEUTIC
EP1893130A4 (en) * 2005-06-17 2015-08-26 Georgia Tech Res Inst COATED MICROSTRUCTURES AND METHOD FOR THE PRODUCTION THEREOF
ATE477833T1 (de) 2005-06-27 2010-09-15 3M Innovative Properties Co Mikronadelkartuschenanordnung
CN101227940A (zh) * 2005-07-25 2008-07-23 纳米技术维多利亚有限公司 微阵列装置
US20070249546A1 (en) * 2006-04-22 2007-10-25 Sawaya Assad S Ophthalmic and related aqueous solutions containing antifungal agents, uses therefor and methods for preparing them
MX2009001533A (es) 2006-08-11 2009-02-18 Panacea Biotec Ltd Particulas para el suministro de ingredientes activos, procedimiento de elaboracion y sus composiciones.
WO2008073558A2 (en) * 2006-10-05 2008-06-19 The Johns Hopkins University Water-dispersible oral, parenteral, and topical formulations for poorly water soluble drugs using smart polymeric nanoparticles
WO2010011354A2 (en) * 2008-07-25 2010-01-28 Innovation Biomedical Devices, Inc. Enchanced trans-keratin drug delivery
CN101724284B (zh) * 2008-10-31 2012-06-27 中国石油化工股份有限公司 一种抗菌热塑性塑料组合物及其制备方法
JP5408592B2 (ja) * 2010-03-19 2014-02-05 コスメディ製薬株式会社 マイクロニードルの迅速溶解法
JP2012235899A (ja) 2011-05-12 2012-12-06 Bioserentack Co Ltd 大量の目的物質を皮膚内へデリバリーするためのマイクロニードル・アレイ・チップ
BR112013033239A2 (pt) * 2011-06-22 2016-09-06 Vyome Biosciences pró-farmácos de conjugado baseado em atifungicos e antibacterianos
GB201117538D0 (en) * 2011-10-11 2011-11-23 Royal Veterinary College The Methods
EP2664327A1 (en) * 2012-05-14 2013-11-20 Almirall S.A. Topical pharmaceutical compositions comprising terbinafide and urea
GB201317005D0 (en) * 2013-09-25 2013-11-06 Blueberry Therapeutics Ltd Composition and methods of treatment

Also Published As

Publication number Publication date
JP2016536271A (ja) 2016-11-24
CN105579028B (zh) 2020-03-20
EP3501498A1 (en) 2019-06-26
EP3501498B1 (en) 2020-11-25
WO2015044669A1 (en) 2015-04-02
SI3049056T2 (sl) 2022-08-31
EP3049056B2 (en) 2022-06-01
CY1123414T1 (el) 2022-03-24
ES2738662T3 (es) 2020-01-24
DK3049056T3 (da) 2019-07-29
JP7028836B2 (ja) 2022-03-02
SI3049056T1 (sl) 2019-11-29
EP3049056B1 (en) 2019-04-24
ES2859518T3 (es) 2021-10-04
HUE044589T2 (hu) 2019-11-28
RS59211B1 (sr) 2019-10-31
HRP20191304T1 (hr) 2019-10-18
EP3854380A1 (en) 2021-07-28
LT3049056T (lt) 2019-08-26
PT3049056T (pt) 2019-07-25
US20160206567A1 (en) 2016-07-21
GB201317005D0 (en) 2013-11-06
SMT201900437T1 (it) 2019-09-09
EP3049056A1 (en) 2016-08-03
US20220133640A1 (en) 2022-05-05
US12161764B2 (en) 2024-12-10
DK3049056T4 (da) 2022-08-01
JP6581569B2 (ja) 2019-09-25
JP2019218393A (ja) 2019-12-26
CN105579028A (zh) 2016-05-11
ES2738662T5 (es) 2022-09-21
RS59211B2 (sr) 2022-07-29
GB201320723D0 (en) 2014-01-08
US11185511B2 (en) 2021-11-30
PL3049056T3 (pl) 2019-10-31
PL3049056T5 (pl) 2022-09-12

Similar Documents

Publication Publication Date Title
HRP20191304T4 (hr) Antigljivični pripravak i postupci liječenja
JP2016536271A5 (https=)
WO2013174615A3 (en) Personal care composition comprising a colling active and a copolymer comprising acrylamidopropyltrimonium chloride
WO2014030770A3 (en) Copolymer having carbosiloxane dendrimer structure and hydrophilic group
MX2014015657A (es) Composicion topica que comprende un polimero formador de pelicula para liberar un ingrediente activo a la piel.
BR112015010772A2 (pt) composição de enxágue tópica, uso de uma composição e método para tratar ou melhorar a pele de um indivíduo contra a acne
CO2018001375A2 (es) Composiciones de retinoides tópicos
WO2011156030A3 (en) High oil-content emollient aerosol foam compositions
BR112015005339A8 (pt) uso de óleo de semente de fruta milagrosa como um ingrediente ativo
WO2011088333A3 (en) Solid-forming local anesthetic formulations for pain control
WO2013079605A3 (en) Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition
SA113340494B1 (ar) تركيبة لعلاج اضطرابات أيضية
BR112014026427A2 (pt) formulação antiaderente incluindo um composto de amônio quaternário e um álcool graxo
ME02199B (me) Nova farmaceutska formulacija za tretman gljivičnih infekcija
WO2014121048A3 (en) Topical compositions and methods for making and using same
WO2014102483A3 (fr) Composition cosmetique ou dermatologique a base d'extraits d'iris et son utilisation
HK1222337A1 (zh) 用於施加药物活性成分或化妆品活性成分的局部组合物和载体
FR2998782B1 (fr) Emulsion cosmetique eau-dans-huile notamment conditionnee sous forme d'aerosol comprenant au moins un polymere vinylique, au moins un copolymere d'olefine et au moins un actif anti-transpirant
HK1252057A1 (zh) 新颖的使用方法和组合物
FR2999086B1 (fr) Composition orale et/ou buccale sous forme de film fin d'un principe actif faiblement soluble, son procede de preparation et son utilisation
BR112015018798A2 (pt) composição antifúngica tópica para tratar onocomicose
WO2015063613A3 (en) Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
BR112014004737A2 (pt) composto de composição de cloridrato de ambroxol e método de preparação do composto
JP2019509281A5 (https=)
JP2016074737A5 (https=)